| Followers | 1353 |
| Posts | 273325 |
| Boards Moderated | 57 |
| Alias Born | 12/07/2009 |
Monday, June 30, 2025 2:32:15 PM
https://cadrenal.com/pipeline/
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Recent CVKD News
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 12:05:43 PM
- Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes • GlobeNewswire Inc. • 03/12/2026 12:00:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2026 01:35:37 PM
- Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement • GlobeNewswire Inc. • 02/24/2026 01:30:00 PM
- Cadrenal Therapeutics Highlights High Incidence of Thrombotic Complications in Heparin-Induced Thrombocytopenia (HIT) at the J.P. Morgan Healthcare Conference and VLX-1005 as a Potential Therapeutic Solution as the First and Only Selective 12-LOX Inhibitor • GlobeNewswire Inc. • 01/12/2026 01:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/02/2026 09:05:24 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/02/2026 05:15:35 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/29/2025 09:25:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 09:58:54 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/23/2025 09:56:48 PM
- Cadrenal Therapeutics to Conduct Partnering and Investor Meetings During the J.P. Morgan 44th Annual Healthcare Conference in San Francisco on January 12-15, 2026 • GlobeNewswire Inc. • 12/17/2025 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2025 01:24:18 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/16/2025 01:21:37 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/16/2025 01:18:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2025 01:17:00 PM
- Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT) • GlobeNewswire Inc. • 12/11/2025 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 02:05:24 PM
- Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors • GlobeNewswire Inc. • 12/01/2025 02:00:00 PM
- Cadrenal Therapeutics CEO, Quang X. Pham, Receives BioFlorida’s Executive of the Year Award • GlobeNewswire Inc. • 11/19/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2025 09:23:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/18/2025 09:20:04 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
